Inherited risk of coronary artery disease: redefining care with imaging and genetics

Nick S R Lan1,2,3, Girish Dwivedi1,2,3,4, Graham S Hillis1,5

  • 1Medical School, The University of Western Australia, Perth, Western Australia, Australia.

Nature Reviews. Cardiology
|February 11, 2026
PubMed

Insights

Family history is a key predictor of coronary artery disease (CAD) risk. New cardiac imaging and genomic tools can improve precision prevention for families with high CAD risk.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Preventative Medicine

Background:

  • Atherosclerotic cardiovascular disease is a major global health burden.
  • Family history of premature coronary artery disease (CAD) is an established risk factor, reflecting genetic and environmental influences.
  • Current use of family history in cardiovascular risk assessment is inconsistent and under-recorded.

Purpose of the Study:

  • To review mechanisms of inherited CAD risk.
  • To identify limitations of current family history-based risk stratification.
  • To explore the role of cardiac imaging and polygenic risk scores in refining CAD risk assessment.

Main Methods:

  • Synthesizing pathogenic mechanisms of inherited CAD risk.
  • Analyzing limitations of traditional family history in risk models.
  • Evaluating the integration of cardiac imaging and genomic data (polygenic risk scores).

Main Results:

  • Family history, while valuable, has limitations in current risk models.
  • Cardiac imaging and polygenic risk scores offer enhanced precision for cardiovascular risk assessment.
  • Integrating traditional and novel tools can enable lifelong precision prevention strategies.

Conclusions:

  • Advances in cardiac imaging and genomics enable a more precise approach to cardiovascular disease prevention.
  • There is a need to update guidelines to incorporate novel risk assessment tools.
  • Future research should focus on equity, cost-effectiveness, and implementation of new preventative strategies.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
368